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some built-in investigator bias toward
robust responsiveness in the model
systems. In the case of CD8+ T cells
specific for pathogens, most bind well
to tetrameric reagents, but for class II
MHC responses, clearly some do not
(Novak et al., 1999). Thus, the numbers
obtained here are likely to be underes-
timates, but by how much is not clear. It
is also important to point out that the
study discussed here did not investi-
gate the numerous ab T cells (107)
found in the gut, and it would be inter-
esting to know whether the ab cells
found in that compartment exhibit
a similar or distinct repertoire.
This work also speaks to the size of
the overall ab T cell repertoire in that
the authors note a diversity of Vbs in
their ligand-specific populations. This
indicates that there is considerable
T cell receptor (TCR) diversity in these
pools of T cells, consistent with calcu-
lations of the potential ab TCR diver-
sity of 1015 (Davis and Bjorkman
1988) and with the work of Bousso
et al. (1998) showing that individual
mice of the same strain nonetheless
expressed different TCR sequences.
It would be interesting to know whether
humans, with their much larger number
of T cells, have more cells devoted to
a given specificity or perhaps have a
larger number of specificities. It is
also intriguing to wonder why the li-
gand-specific T cell repertoire for ab
T cells in mice (106–107 seems like
a reasonable compromise figure with-
out trying to account for crossreactiv-
ity) is so nearly identical to that found
for the B cell repertoire for mice in the
pioneering studies of Klinman and
colleagues (Cancro et al., 1978).
The beauty of the approach devel-
oped by Moon et al. lies not only in
the technically superiority of this
method for counting T cells of a given
specificity, but also in the fact that
one could have the T cells of interest
‘‘in hand,’’ allowing all sorts of manipu-
lations and analyses (of TCR diversity,
for example) that will be invaluable for
future studies. It will also move our dis-
cussions of T cell repertoires from the
realm of speculation and philosophy
to much more solid terrain.
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Activated CD8+ T cells can differentiate into transient effector cells or long-lived memory cells. In this
issue of Immunity, Joshi et al. (2007) suggest that inflammatory cytokines dictate this balance by
regulating the expression of the transcription factor T-bet.The adaptive immune response against
pathogens has twin goals: to provide
functional effector cells that augment
and extend innate immune protection,
and to establish immune memory, ca-
pable of mounting a quicker and more
robust response to the same pathogen
when encountered long into the future.
The achievement of these distinct ob-180 Immunity 27, August 2007 ª2007 Eljectives requires the differential main-
tenance of stimulated lymphocytes:
Effector cells are needed in vast num-
bers but for a short time, whereas the
raison d’eˆtre of the antigen-reactive
memory pool is that it should be long-
lived yet low frequency (to maintain
immune diversity). How and when is
this balancing act regulated?sevier Inc.Previous work showed that precur-
sors of the memory pool were evident
as a rare population of IL-7Ra+ cells in
the effector population (Kaech et al.,
2003). The current report (Joshi et al.,
2007) extends these earlier studies to
show that the expression of the natural
killer (NK) cell receptor KLRG1 can
be used even earlier in the immune
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Previewsresponse (at stages when IL-7Ra is
uniformly low) to identify cells that are
destined to become short-lived effec-
tor cells (SLECs). KLRG1 (and, at later
time points, IL-7Ra) expression there-
fore offered a way to separate acti-
vated cells into those destined to be
SLECs versus a pool containing mem-
ory precursor effector cells (MPECs).
Although useful, these markers did
not provide a direct insight into the
mechanism of SLEC versus MPEC de-
cision. Reactivity to interleukin-7 (IL-7)
(requiring IL-7Ra) is necessary for the
generation and maintenance of CD8+
memory T cells (Kaech et al., 2003;
Schluns et al., 2000), but recent work
suggests IL-7Ra re-expression is not
sufficient to drive effector cell differen-
tiation into the memory pool (Hand
et al., 2007). The role of KLRG1 is
even more obscure: This molecule
has been proposed to mark senescent
cells, yet the authors find little impact of
KLRG1 knockdown on SLEC produc-
tion or longevity (Joshi et al., 2007).
Nevertheless, these markers permitted
the assessment of how other stimuli
alter early effector cell commitment
into SLEC versus MPEC fates—and
to begin identifying the transcription
factors controlling the decision making
process.
Inflammatory cytokines could influ-
ence the relative frequency of effector
versus memory cells. Harty and col-
leagues found that limiting inflamma-
tory cues during CD8+ T cell priming
reduced the contraction phase of the
response, resulting in more-efficient
memory cell generation from the effec-
tor pool (Badovinac et al., 2004). Si-
milarly, responses of IL-12-deficient
animals to attenuated Listeriamonocy-
togenes show the improved produc-
tion of memory cells (Takemoto et al.,
2006). Studies from Mescher and col-
leagues have shown that both IL-12
and type I interferon (IFN) can promote
the differentiation of activated T cells
into effector cells (Curtsinger et al.,
2005). How do inflammatory cytokines
impact the early appearance of SLECs
and MPECs?
Joshi et al. also observe that in vivo
inflammatory signals enhance the fre-
quency of SLECs at the expense of
MPECs, an effect that could be repli-
cated by the administration of IL-12in vitro. They go on to explore how
these signals alter the expression of
the transcription factor T-bet. T-bet
and its close relative eomesodermin
(Eomes) are important for both effector
and memory CD8+ T cell differentiation
(Intlekofer et al., 2005; Pearce et al.,
2003). T-bet is induced by T cell recep-
tor (TCR) stimulation, but Joshi et al.
show that T-bet expression is boosted
by increasing dosesof IL-12, in line with
previous studies (Takemoto et al.,
2006). Intriguingly, Joshi et al. show
that T-bet deficiency leads to a pro-
found absence of KLRG1hi IL-7Ralo
cells, suggesting a key requirement
for T-bet in SLECs production. The
link between T-bet expression and
SLEC differentiation was reinforced
by the use of T-bet heterozygous
mice and an inducible T-bet expression
system, with both approaches indicat-
ing that titrating up the amounts of
T-bet promotes SLEC over MPEC
commitment (Joshi et al., 2007).
So, do these data argue that T-bet
expression, driven by IL-12, is a digital
switch dictating SLEC versus MPEC
fates? The system is likely to be more
subtle than that (Figure 1). First, some
minimal amount of T-bet appears to
be required for normal memory T cell
generation. Although Joshi et al. report
that T-bet-deficient CD8+ T cells are
strongly skewed toward the MPEC
pathway, the resulting T-bet-deficient
memory CD8+ T cells failed to upregu-
late CD122 (the b-chain of IL-2 and IL-
15 receptors), a hallmark of normal
CD8+ memory T cells (Joshi et al.,
2007). One might predict that T-bet-
deficient memory cells will fail to
undergo basal proliferation, an IL-15
driven process that maintains the nor-
mal CD8+ memory T cell pool (Williams
and Bevan, 2007). Such data suggest
that memory CD8+ T cell differentiation
follows a ‘‘Goldilocks’’ model, in which
amounts of T-bet need to be ‘‘just
right’’ for memory pool production:
Too much T-bet diverts cells to the
SLEC pathway, whereas too little T-
bet (perhaps reflecting a poor TCR sig-
nal) would shunt the cells into an alter-
native pool of memory-like cells that
are impaired in sensing homeostatic
signals from IL-15.
Second, as discussed above, T-bet
has a close cousin, Eomes. The two
factors exhibit distinct expression
patterns during CD8+ T cell differentia-
tion and, relevant to the current study,
IL-12 induces T-bet expression,
whereas it inhibits Eomes transcription
(Intlekofer et al., 2005; Takemoto et al.,
2006). Furthermore, Eomes can also
regulate CD122 expression, indepen-
dent of T-bet (Intlekofer et al., 2005).
Might Eomes play an overlapping (or
opposing) role in regulating CD8+ T
Figure 1. Model for the Role of Inflammatory Cytokines and T-bet in Directing
Differentiation of Activated CD8+ T Cells
IL-12 promotes the expression of T-bet (and can repress Eomes) in activated CD8+ T cells.
Increased T-bet levels (blue shading) lead to elevated frequencies of KLRG1hi IL-7Ralo SLECs
over KLRG1lo IL-7Rahi MPECs (represented by the balance of red and green cells, respectively).
Whether Eomes participates in regulating these pathways is unclear, as is the role of other inflam-
matory cytokines in dictating T-bet expression or SLEC-MPEC decision making.Immunity 27, August 2007 ª2007 Elsevier Inc. 181
Immunity
Previewscell differentiation? Although the cur-
rent report shows that manipulating
the amount of T-bet can influence the
SLEC versus MPEC decision, this
outcome might involve an effect on
Eomes activity (competition for shared
target genes, for example). Joshi et al.
state that Eomes expression is similar
in KLRG1+ and KLRG1 early effector
cells, but given the mild changes in
Eomes expression during CD8+ T cell
differentiation (Intlekofer et al., 2005;
Takemoto et al., 2006), this might not
be fully conclusive either. Further work
will be needed to explore whether the
balance between T-bet and Eomes
dictates the fate of activated CD8 T
cells.
Third, the impact of additional in-
flammatory cytokines other than IL-12
on SLEC versus MPEC fates is unclear.
Data from Harty’s group indicated that
IFN-g deficiency favored the genera-
tion of memory cells from early effec-
tors in vivo (Badovinac et al., 2004). In
seeming contrast, Joshi et al. report
that IFN-g was unable to directly pro-
mote SLEC differentiation of in vitro
stimulated cells. However, Joshi et al.
comment that they also observe fewer
SLECs in immunized IFN-g-deficient
mice but correlate this with a failure
to produce active IL-12. Such data
suggest IFN-g might, in certain situa-
tions, act through the induction of
IL-12 (an interesting reversal of their
normal roles). Furthermore, although
some infections (such as L. Monocyto-
genes) induce robust amounts of IL-12,
other pathogens (like the lymphocytic
choriomeningitis virus, extensively
used by Joshi et al.) preferentially pro-
voke the production of type I IFN—a cy-
tokine that can also promote CD8+ T
cell effector differentiation (Curtsinger
et al., 2005). It will be interesting to
see whether type I IFN (like IL-12) influ-182 Immunity 27, August 2007 ª2007 Elsences T-bet (or Eomes) expression, or
whether the effects of this cytokine op-
erate through a distinct mechanism.
The current work by Joshi et al. rein-
forces the widely held view that the
‘‘correct’’ amount of inflammation is
critical for the construction of the
memory pool and shows us a mecha-
nism by which inflammatory cytokines
mediate the formation of SLECs
through expression of T-bet. Although
one important criteria of a memory cell
is its longevity, it will be of interest to
examine whether the phenotypic and
functional characteristics of MPECs
(e.g., central versus effector memory
subsets) and their ability to undergo
protective recall responses is also
influenced by amounts of inflamma-
tion and/or T-bet. Interestingly, recent
studies by Reiner’s group indicate
that T-bet deficiency favors the gener-
ation of central rather than effector
memory cells (Steve Reiner, personal
communication), arguing for T-bet’s
influence beyond the SLEC stage.
Previous work has shown that limit-
ing the contraction phase and thereby
increasing the memory cell pool is
possible if robust inflammation is pre-
vented. In the context of the current
work, it might therefore be possible
to prevent the formation of SLECs
and boost antigen-specific memory
through immunization. However, as it
is becoming clear that many types of
phenotypically and functionally distinct
memory populations exist (and presum-
ably benefit the host), so too might mul-
tiple types of effector cells be advanta-
geous. This raises the issue of whether
SLEC and MPEC formation are mutually
exclusive; forexample,caneffectorcells
be generated without impairing memory
cell numbers in the same response? In
their analysis of T-bet-deficient and het-
erozygous mice, Joshi et al. find similarevier Inc.MPEC numbers, whereas the size of
the SLEC pool is drastically altered;
yet their studies and earlier work (Ba-
dovinac et al., 2004) also suggest that
inflammatory cues promote SLEC pro-
duction at the expense of MPEC. The
current report provides insight into
effector cell commitment and might
suggest vaccine approaches that tem-
per T-bet expression to efficiently gen-
erate both SLEC and MPEC path-
ways—letting the immune system
have its cake and eat it too.
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